M&A

Unilever explores potential all-stock Foods spin-off to McCormick, shifting focus to higher-margin beauty and personal care segments in transformative restructuring.

Prestige Consumer Healthcare agrees to acquire Breathe Right nasal strip brand for $1.045 billion, targeting sleep and respiratory health categories with expected margin expansion and free cash flow benefits by H1 2027.

Prestige Consumer Healthcare to acquire Breathe Right and related OTC brands from Foundation Consumer Healthcare for $1.045 billion, expected immediately accretive to earnings and margins.

Embecta to acquire UK firm Owen Mumford for up to $200M, bolstering drug-delivery capabilities and chronic care market reach. Stock rises 4.63%.

Institutional investors rotate capital to precision oncology biotech as patent cliff pressures Big Pharma. Five clinical-stage companies positioned for M&A amid $303B market opportunity.

Mastercard agrees to acquire stablecoin infrastructure firm BVNK for up to $1.8B, targeting rapid digital asset growth and cross-currency money movement.

Iveco confirms all closing conditions met for Leonardo defence business sale, clearing final hurdle for Tata Motors' $3.8B acquisition to proceed.

HF Foods reports Q4 revenue growth of 2.2% to $1.23B and EBITDA rise of 6.9%, completes ERP digital transformation, and positions itself as consolidator in $50B Asian specialty foodservice market.

Mawson Infrastructure regains Nasdaq compliance, settles $19M lawsuits, establishes M&A committee to pursue AI infrastructure opportunities.

Papa John's receives $1.5B privatization proposal from Irth Capital/Brookfield. Shell sells Jiffy Lube for $1.3B. Meta acquires Moltbook; Google closes $32B Wiz deal.

AstraZeneca has exclusive access to Abivax data until March 23. If it misses deadline, Eli Lilly could rejoin bidding for French biotech valued by 1,600% surge.

Monteverde & Associates launches investigation into Cathedra Bitcoin's merger with Sphere 3D, questioning deal fairness for shareholders receiving 0.123 shares per stake.

Medtronic acquires Scientia Vascular for $550M to strengthen neurovascular offerings. Deal closes H1 FY2027, minimally dilutive in 2027, then accretive.

Mowi acquires Torghatten Aqua's Norwegian sea-farming operations for NOK 293M, adding 2,628-tonne biomass capacity and divesting its 33.34% stake.

Agilent acquires Biocare Medical for $950M to expand pathology and immunohistochemistry capabilities. Deal expected accretive to EPS within 12 months, closing by Q4 2026.

Woodward acquires Florida-based VRM to strengthen aerospace flow control capabilities, adding solenoid and relief valves to its portfolio. Deal closes H1 2026.

Nestlé sells Blue Bottle; Netflix acquires AI startup InterPositive; Six Flags divests parks; Eddie Bauer bankruptcy auction fails; Cumulus Media files Chapter 11 restructuring.

Prediction market traders assign 68% probability to Caesars Entertainment acquisition in 2026, with potential bidders including Tilman Fertitta. Analysts caution investors to focus on fundamentals over M&A speculation.

Diana Shipping escalates takeover battle, raising Genco offer to $23.50/share from $20.60 amid Star Bulk vessel acquisition.

Star Bulk to acquire 16 Diana Shipping vessels for $470.5M, contingent on Diana's Genco takeover. Fleet expands to 157 ships with 15.9M dwt capacity.